Skip to main content
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

MTRC Access Intelligence Mobile App Now Available on the App Store

We are pleased to announce that the MTRC Access Intelligence mobile app is now available on the App Store, making it easier for MedTech, IVD, and digital health professionals to stay informed about important market access developments. 

The mobile app is available at no additional cost to all active MTRC Access Intelligence Database subscribers. Existing subscribers can simply download the app and access the same market access intelligence included in their current subscription, anytime and anywhere. 

MTRC Access Intelligence is a specialized market access monitoring service that tracks reimbursement, coding, health technology assessment (HTA), payer decisions, clinical guidelines, and other market access developments across Europe and globally. 

At the core of the service is a structured online database that allows users to explore historical developments, search by keyword, and filter information by country, technology group, and market access pathway. It helps market access, reimbursement, and HEOR teams identify relevant changes, monitor emerging opportunities and risks, and support evidence planning, market prioritization, and portfolio decisions. 

With the launch of the mobile app, users now have another convenient way to access MTRC Access Intelligence and stay connected to relevant market access information. 

Download the App on the App Store 

Learn more about MTRC Access Intelligence